drugset / Trial / NCT04273763
Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19)
Unknown
18 enrolled
Second Affiliated Hospital of Wenzhou Medical University
Wanbangde Pharmaceutical Group Co., LTD · collab
RandomizedSequentialOpen-labelTreatment
Summary
Compare the efficacy and safety of Bromhexine Hydrochloride Tablets combined with standard treatment/ standard treatment in patients with suspected and mild, or common novel coronavirus pneumonia (COVID-19). Random, open, group sequential design.
Timeline
- Start
- 2020-02-16
- Primary completion
- 2020-05-10
- Completion
- 2020-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bromhexine | Small molecule | — | — |
| Background | Recombinant Human Interferon α2b | Protein / enzyme biologic | — | — |
| Background | Umifenovir | Small molecule | — | — |